Cargando…

Cardiac events after macrolides or fluoroquinolones in patients hospitalized for community-acquired pneumonia: post-hoc analysis of a cluster-randomized trial

BACKGROUND: Guidelines recommend macrolides and fluoroquinolones in patients hospitalized with community-acquired pneumonia (CAP), but their use has been associated with cardiac events. We quantified associations between macrolide and fluoroquinolone use and cardiac events in patients hospitalized w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Postma, Douwe F., Spitoni, Cristian, van Werkhoven, Cornelis H., van Elden, Leontine J. R., Oosterheert, Jan Jelrik, Bonten, Marc J. M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6322338/ https://www.ncbi.nlm.nih.gov/pubmed/30612559 http://dx.doi.org/10.1186/s12879-018-3630-7

Ejemplares similares

Predictors of Bacteraemia in Patients with Suspected Community-Acquired Pneumonia
por: van Werkhoven, Cornelis H., et al.
Publicado: (2015)

Cost-effectiveness of antibiotic treatment strategies for community-acquired pneumonia: results from a cluster randomized cross-over trial
por: van Werkhoven, Cornelis H., et al.
Publicado: (2017)

Community-Acquired Pneumonia—Back to Basics
por: Bonten, Marc J.M., et al.
Publicado: (2008)

Confounding by indication of the safety of de-escalation in community-acquired pneumonia: A simulation study embedded in a prospective cohort
por: van Heijl, Inger, et al.
Publicado: (2019)

Fluoroquinolone and Macrolide Treatment Failure in Pneumococcal Pneumonia and Selection of Multidrug-Resistant Isolates
por: Pérez-Trallero, Emilio, et al.
Publicado: (2003)

Respiratory Fluoroquinolones Monotherapy vs. β-Lactams With or Without Macrolides for Hospitalized Community-Acquired Pneumonia Patients: A Meta-Analysis
por: Liu, Sitong, et al.
Publicado: (2019)

Increasing Macrolide and Fluoroquinolone Resistance in Mycoplasma genitalium
por: Murray, Gerald L., et al.
Publicado: (2017)

Macrolides and community-acquired pneumonia: is quorum sensing the key?
por: Wise, Matt P, et al.
Publicado: (2010)

A Review of the Resistance Mechanisms for β-Lactams, Macrolides and Fluoroquinolones among Streptococcus pneumoniae
por: Zahari, Nurul Izzaty Najwa, et al.
Publicado: (2023)

Macrolide-resistant Mycoplasma pneumoniae in adolescents with community-acquired pneumonia
por: Miyashita, Naoyuki, et al.
Publicado: (2012)

Treatment with macrolides and glucocorticosteroids in severe community-acquired pneumonia: A post-hoc exploratory analysis of a randomized controlled trial
por: Ceccato, Adrian, et al.
Publicado: (2017)

2225. Are Fluoroquinolones or Macrolides Better for Treating Legionella Pneumonia? A Systematic Review and Meta-Analysis
por: Jasper, Annie S, et al.
Publicado: (2019)

Macrolide-Resistant Mycoplasma pneumoniae Infections in Pediatric Community-Acquired Pneumonia
por: Chen, Yu-Chin, et al.
Publicado: (2020)

Efficacy of tetracyclines and fluoroquinolones for the treatment of macrolide-refractory Mycoplasma pneumoniae pneumonia in children: a systematic review and meta-analysis
por: Ahn, Jong Gyun, et al.
Publicado: (2021)

The comparative development of elevated resistance to macrolides in community-acquired pneumonia caused by Streptococcus pneumoniae
por: Yayan, Josef
Publicado: (2014)

First Description of Macrolide-Resistant Mycoplasma pneumoniae in Adults with Community-Acquired Pneumonia in Italy
por: Loconsole, Daniela, et al.
Publicado: (2019)

Detection and Prevalence of Macrolide and Fluoroquinolone Resistance in Mycoplasma genitalium in Badalona, Spain
por: Rivaya, Belén, et al.
Publicado: (2022)

Mycoplasma genitalium macrolide and fluoroquinolone resistance in pregnant women in Papua New Guinea
por: Jonduo, Marinjho E, et al.
Publicado: (2023)

Do fluoroquinolones actually increase mortality in community-acquired pneumonia?
por: Agarwal, Ritesh
Publicado: (2006)

Linear Regression Equations To Predict β-Lactam, Macrolide, Lincosamide, and Fluoroquinolone MICs from Molecular Antimicrobial Resistance Determinants in Streptococcus pneumoniae
por: Demczuk, Walter, et al.
Publicado: (2022)

Is β-Lactam Plus Macrolide More Effective than β-Lactam Plus Fluoroquinolone among Patients with Severe Community-Acquired Pneumonia?: a Systemic Review and Meta-Analysis
por: Lee, Jong Hoo, et al.
Publicado: (2017)

Genotyping and macrolide resistance of Mycoplasma pneumoniae identified in children with community-acquired pneumonia in Medellín, Colombia
por: Copete, Angela Rocio, et al.
Publicado: (2018)

Synergistic anti-Campylobacter jejuni activity of fluoroquinolone and macrolide antibiotics with phenolic compounds
por: Oh, Euna, et al.
Publicado: (2015)

Genetic Determinants of Macrolide and Fluoroquinolone Resistance in Mycoplasma genitalium and Their Prevalence in Moscow, Russia
por: Edelstein, Inna Alexandrovna, et al.
Publicado: (2023)

The impact of 13-valent pneumococcal conjugate vaccination on virus-associated community-acquired pneumonia in elderly: Exploratory analysis of the CAPiTA trial
por: Huijts, S.M., et al.
Publicado: (2018)

Macrolides Decrease the Proinflammatory Activity of Macrolide-Resistant Streptococcus pneumoniae
por: Domon, Hisanori, et al.
Publicado: (2023)

Macrolide versus Non-Macrolide in Combination with Steroids for the Treatment of Lobar or Segmental Mycoplasma pneumoniae Pneumonia Unresponsive to Initial Macrolide Monotherapy
por: Bae, Eunha, et al.
Publicado: (2022)

812 Macrolide Use and Innate Immunity Components in Hospitalized Patients with Community-Acquired Pneumonia
por: Arnold, Forest W., et al.
Publicado: (2014)

Macrolide Resistance in Streptococcus pneumoniae
por: Schroeder, Max R., et al.
Publicado: (2016)

1325. Macrolide versus Non-macrolide in Combination with Steroids for the Treatment of Lobar or Segmental Mycoplasma Pneumoniae Pneumonia Unresponsive to Initial Macrolide Monotherapy
por: Bae, Eunha, et al.
Publicado: (2022)

Macrolide-Resistant and Macrolide-Sensitive Mycoplasma pneumoniae Pneumonia in Children Treated Using Early Corticosteroids
por: Han, Hye Young, et al.
Publicado: (2021)

Comparative Treatment Failure Rates of Respiratory Fluoroquinolones or β-Lactam + Macrolide Versus β-Lactam Alone in the Treatment for Community-Acquired Pneumonia in Adult Outpatients: An Analysis of a Nationally Representative Claims Database
por: Lee, Meng-Tse Gabriel, et al.
Publicado: (2015)

Moving Past the Routine Use of Macrolides—Reviewing the Role of Combination Therapy in Community-Acquired Pneumonia
por: Shumilak, Geoffrey, et al.
Publicado: (2018)

Macrolide and fluoroquinolone resistance-associated mutations in Mycoplasma genitalium in Johannesburg, South Africa, 2007–2014
por: Muller, Etienne E., et al.
Publicado: (2019)

Bleeding events among patients concomitantly treated with direct oral anticoagulants and macrolide or fluoroquinolone antibiotics
por: Yagi, Tatsuya, et al.
Publicado: (2022)

Predictive value of C-reactive protein in response to macrolides in children with macrolide-resistant Mycoplasma pneumoniae pneumonia
por: Seo, Young Ho, et al.
Publicado: (2014)

Macrolide susceptibility and serotype specific macrolide resistance of invasive isolates of Streptococcus pneumoniae in Germany from 1992 to 2008
por: Imöhl, Matthias, et al.
Publicado: (2010)

Does empirical treatment of community-acquired pneumonia with fluoroquinolones delay tuberculosis treatment and result in fluoroquinolone resistance in Mycobacterium tuberculosis? Controversies and solutions
por: Shen, Gwan-Han, et al.
Publicado: (2012)

Fluoroquinolone-resistant Streptococcus pneumoniae
por: Pletz, Mathias W.R., et al.
Publicado: (2006)

Comparative Treatment Failure Rates of Respiratory Fluoroquinolones or β-Lactam + Macrolide Versus β-Lactam Alone in the Treatment for Community-Acquired Pneumonia in Adult Outpatients: An Analysis of a Nationally Representative Claims Database: Erratum
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_40jck3gkbm7ffrd6f4lt0jlcg4